This large-scale analysis of the National Cancer Database (NCDB) highlights some interesting trends in the current use of systemic therapy in patients with NSCLC who undergo pneumonectomy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
September 15, 2023
June 15, 2023
A new expert consensus on diagnosis, staging, and therapy for early-stage non-small cell lung cancer patients has been released. The experts recommend CT and PET imaging as a necessary part of the diagnosis and staging phase.
May 4, 2023
A systematic review of prognostic factors for five-year survival after pulmonary metastasectomy (PM) from colorectal cancer (CRC) identified 11 of 77 preoperative factors as having statistically significant positive effects. These included a solitary metastasis < 2 cm.
March 23, 2023
Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis, focusing on pharmacological and mechanical methods.
March 2, 2023
This study aimed to determine risk factors that lead to hospital readmission after lobectomy.
February 16, 2023
Sleeve lobectomy is preferred to pneumonectomy for centrally located lung tumors. To report on surgical outcomes of this procedure, The European Society of Thoracic Surgeons database was searched between 2007 and 2021.
February 3, 2023
Since time to surgery for lung cancer is not well established, researchers aimed to assess whether time to surgery from diagnosis correlates with outcomes like unplanned return to care, mortality, and disease recurrence.
January 6, 2023
The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light.
Minimum Volume Standards for Surgical Care of Early-Stage Lung Cancer: A Cost-Effectiveness Analysis
December 21, 2022
This study aimed to determine the cost-effectiveness of receiving surgical resection for non-small cell lung cancer at hospitals that perform at least forty lung resections annually.
December 9, 2022
Researchers have been awarded a grant to fund cancer vaccine research, including the development of an mRNA vaccine that would target precancerous lung lesions.